Physician profile
Mitchell N Williams
NPI 1194990077
$2,466.09
in general payments reported to CMS, 2019-2025
37 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $220 · 2021: $339 · 2022: $280 · 2023: $428 · 2024: $415 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,321.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $448.36 | 2024-2025 | |
| Smith+Nephew, INC. | $312.36 | 2019-2024 | Collagenase Santyl |
| Stryker Corporation | $186.00 | 2024-2025 | Ortholoc 2 Lapifuse, Prostep Mica, 7 X 23mm Citrelock Implant |
| Paratek Pharmaceuticals, INC. | $148.83 | 2020-2024 | Nuzyra |
| Novastep INC. | $148.26 | 2021 | |
| Medartis INC. | $143.20 | 2023 | Aptus |
| Tactile Systems Technology INC | $96.60 | 2020-2022 | |
| Nevro Corp. | $80.22 | 2022 | |
| Melinta Therapeutics, LLC | $78.62 | 2019-2022 | |
| Abbvie INC. | $68.02 | 2022-2024 | Dalvance |
| Organogenesis INC. | $67.88 | 2021-2023 | Puraply |
| Vilex LLC | $64.94 | 2023 | |
| Kci USA, INC. | $56.81 | 2020-2021 | |
| Orthofix Medical, INC. | $42.96 | 2019-2021 | |
| Horizon Therapeutics Plc | $40.49 | 2019-2020 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.